BioSyent Inc. (RX.V)
CAD 11.64
(-0.94%)
CAD 11.64
(-0.94%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 7.47 Million CAD | 7.91% |
| 2022 | 6.98 Million CAD | -14.68% |
| 2021 | 8.18 Million CAD | 62.69% |
| 2020 | 5.03 Million CAD | -6.65% |
| 2019 | 5.38 Million CAD | -20.7% |
| 2018 | 6.79 Million CAD | -0.81% |
| 2017 | 6.85 Million CAD | 19.06% |
| 2016 | 5.75 Million CAD | 13.76% |
| 2015 | 5.05 Million CAD | 18.87% |
| 2014 | 4.25 Million CAD | 75.83% |
| 2013 | 2.41 Million CAD | 72.93% |
| 2012 | 1.39 Million CAD | 170.07% |
| 2011 | 518.06 Thousand CAD | 1047.46% |
| 2010 | 45.14 Thousand CAD | 115.35% |
| 2009 | -294.22 Thousand CAD | 3.7% |
| 2008 | -305.54 Thousand CAD | -89.59% |
| 2007 | -161.15 Thousand CAD | -145.17% |
| 2006 | 356.81 Thousand CAD | 455.4% |
| 2005 | -100.39 Thousand CAD | 67.89% |
| 2004 | -312.65 Thousand CAD | 29.75% |
| 2003 | -445.04 Thousand CAD | -2.16% |
| 2002 | -435.65 Thousand CAD | 4.18% |
| 2001 | -454.66 Thousand CAD | -33.35% |
| 2000 | -340.96 Thousand CAD | 14.76% |
| 1999 | -400 Thousand CAD | 63.64% |
| 1998 | -1.1 Million CAD | -83.33% |
| 1997 | -600 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 1.95 Million CAD | -7.73% |
| 2024 Q1 | 2.08 Million CAD | 38.04% |
| 2023 Q4 | 1.51 Million CAD | -45.75% |
| 2023 Q1 | 1.4 Million CAD | -0.46% |
| 2023 Q3 | 2.78 Million CAD | 59.45% |
| 2023 FY | 7.53 Million CAD | 7.91% |
| 2023 Q2 | 1.74 Million CAD | 24.33% |
| 2022 Q2 | 1.59 Million CAD | -25.25% |
| 2022 Q1 | 2.12 Million CAD | -10.83% |
| 2022 Q3 | 1.85 Million CAD | 16.42% |
| 2022 Q4 | 1.41 Million CAD | -23.7% |
| 2022 FY | 6.98 Million CAD | -14.68% |
| 2021 Q2 | 1.36 Million CAD | -38.85% |
| 2021 Q3 | 2.18 Million CAD | 59.92% |
| 2021 Q4 | 2.38 Million CAD | 8.97% |
| 2021 Q1 | 2.23 Million CAD | 127.66% |
| 2021 FY | 8.18 Million CAD | 62.69% |
| 2020 FY | 5.03 Million CAD | -6.65% |
| 2020 Q3 | 1.24 Million CAD | 233.24% |
| 2020 Q1 | 1.86 Million CAD | 19.71% |
| 2020 Q4 | 983.42 Thousand CAD | -20.95% |
| 2020 Q2 | -933.72 Thousand CAD | -149.97% |
| 2019 Q2 | 812.92 Thousand CAD | -29.66% |
| 2019 FY | 5.38 Million CAD | -20.7% |
| 2019 Q3 | 1.85 Million CAD | 128.61% |
| 2019 Q4 | 1.56 Million CAD | -16.0% |
| 2019 Q1 | 1.15 Million CAD | -42.6% |
| 2018 Q4 | 2.01 Million CAD | 33.28% |
| 2018 Q2 | 2.03 Million CAD | 65.53% |
| 2018 FY | 6.79 Million CAD | -0.81% |
| 2018 Q1 | 1.23 Million CAD | -39.45% |
| 2018 Q3 | 1.51 Million CAD | -25.92% |
| 2017 Q3 | 1.68 Million CAD | -13.72% |
| 2017 FY | 6.85 Million CAD | 19.06% |
| 2017 Q4 | 2.03 Million CAD | 20.47% |
| 2017 Q2 | 1.95 Million CAD | 70.48% |
| 2017 Q1 | 1.14 Million CAD | -25.52% |
| 2016 Q2 | 1.36 Million CAD | 9.33% |
| 2016 Q4 | 1.54 Million CAD | -4.02% |
| 2016 Q1 | 1.24 Million CAD | 24.16% |
| 2016 Q3 | 1.6 Million CAD | 17.97% |
| 2016 FY | 5.75 Million CAD | 13.76% |
| 2015 Q1 | 1.3 Million CAD | 24.69% |
| 2015 Q2 | 1.15 Million CAD | -11.43% |
| 2015 FY | 5.05 Million CAD | 18.87% |
| 2015 Q4 | 1 Million CAD | -37.21% |
| 2015 Q3 | 1.59 Million CAD | 38.36% |
| 2014 Q4 | 1.04 Million CAD | -21.63% |
| 2014 Q3 | 1.33 Million CAD | 11.15% |
| 2014 Q2 | 1.19 Million CAD | 77.56% |
| 2014 Q1 | 675.72 Thousand CAD | 11.67% |
| 2014 FY | 4.25 Million CAD | 75.83% |
| 2013 Q1 | 481.96 Thousand CAD | 32.31% |
| 2013 Q2 | 534.35 Thousand CAD | 10.87% |
| 2013 Q3 | 802.23 Thousand CAD | 50.13% |
| 2013 Q4 | 605.11 Thousand CAD | -24.57% |
| 2013 FY | 2.41 Million CAD | 72.93% |
| 2012 Q4 | 364.26 Thousand CAD | -14.49% |
| 2012 Q3 | 426.01 Thousand CAD | 26.55% |
| 2012 Q2 | 336.62 Thousand CAD | 23.98% |
| 2012 Q1 | 271.51 Thousand CAD | 68.46% |
| 2012 FY | 1.39 Million CAD | 170.07% |
| 2011 Q1 | 2923.00 CAD | -96.36% |
| 2011 FY | 518.06 Thousand CAD | 1047.46% |
| 2011 Q4 | 161.18 Thousand CAD | -32.93% |
| 2011 Q3 | 240.32 Thousand CAD | 111.49% |
| 2011 Q2 | 113.63 Thousand CAD | 3787.58% |
| 2010 Q1 | -52.67 Thousand CAD | 69.5% |
| 2010 Q4 | 80.36 Thousand CAD | -36.58% |
| 2010 Q3 | 126.7 Thousand CAD | 215.99% |
| 2010 Q2 | -109.23 Thousand CAD | -107.38% |
| 2010 FY | 45.14 Thousand CAD | 115.35% |
| 2009 Q1 | -196.9 Thousand CAD | -15.45% |
| 2009 Q4 | -172.71 Thousand CAD | -223.34% |
| 2009 Q2 | -64.63 Thousand CAD | 67.18% |
| 2009 Q3 | 140.02 Thousand CAD | 316.64% |
| 2009 FY | -294.22 Thousand CAD | 3.7% |
| 2008 FY | -305.54 Thousand CAD | -89.59% |
| 2008 Q4 | -170.54 Thousand CAD | -474.58% |
| 2008 Q3 | 45.53 Thousand CAD | 146.31% |
| 2008 Q2 | -98.32 Thousand CAD | -19.62% |
| 2008 Q1 | -82.19 Thousand CAD | 50.34% |
| 2007 Q2 | -156.56 Thousand CAD | -302.28% |
| 2007 FY | -161.15 Thousand CAD | -145.17% |
| 2007 Q1 | -38.91 Thousand CAD | -164.52% |
| 2007 Q4 | -165.52 Thousand CAD | -182.82% |
| 2007 Q3 | 199.85 Thousand CAD | 227.65% |
| 2006 Q1 | 39.77 Thousand CAD | 105.8% |
| 2006 FY | 356.81 Thousand CAD | 455.4% |
| 2006 Q4 | 60.32 Thousand CAD | -80.13% |
| 2006 Q3 | 303.59 Thousand CAD | 747.74% |
| 2006 Q2 | -46.86 Thousand CAD | -217.85% |
| 2005 Q4 | -686 Thousand CAD | -1255.76% |
| 2005 Q3 | 59.35 Thousand CAD | 634.97% |
| 2005 FY | -100.39 Thousand CAD | 67.89% |
| 2005 Q1 | 537.34 Thousand CAD | 468.0% |
| 2005 Q2 | -11.09 Thousand CAD | -102.06% |
| 2004 Q4 | -146.01 Thousand CAD | -368.91% |
| 2004 Q1 | -66.87 Thousand CAD | 72.83% |
| 2004 Q2 | -68.62 Thousand CAD | -2.61% |
| 2004 FY | -312.65 Thousand CAD | 29.75% |
| 2004 Q3 | -31.14 Thousand CAD | 54.62% |
| 2003 Q1 | -185 Thousand CAD | 10.52% |
| 2003 FY | -445.04 Thousand CAD | -2.16% |
| 2003 Q4 | -246.17 Thousand CAD | -843.56% |
| 2003 Q3 | 33.1 Thousand CAD | 157.09% |
| 2003 Q2 | -57.99 Thousand CAD | 68.65% |
| 2002 Q1 | -169.9 Thousand CAD | 28.96% |
| 2002 Q2 | -122.61 Thousand CAD | 27.83% |
| 2002 Q4 | -206.74 Thousand CAD | -379.73% |
| 2002 FY | -435.65 Thousand CAD | 4.18% |
| 2002 Q3 | 73.9 Thousand CAD | 160.28% |
| 2001 Q3 | 54.5 Thousand CAD | 141.58% |
| 2001 Q1 | -138.91 Thousand CAD | -53.88% |
| 2001 FY | -454.66 Thousand CAD | -33.35% |
| 2001 Q4 | -239.18 Thousand CAD | -538.86% |
| 2001 Q2 | -131.07 Thousand CAD | 5.65% |
| 2000 Q4 | -90.27 Thousand CAD | -400.11% |
| 2000 Q3 | 30.08 Thousand CAD | 130.08% |
| 2000 Q2 | -100 Thousand CAD | 50.0% |
| 2000 Q1 | -200 Thousand CAD | 0.0% |
| 2000 FY | -340.96 Thousand CAD | 14.76% |
| 1999 Q3 | 200 Thousand CAD | 300.0% |
| 1999 Q4 | -200 Thousand CAD | -200.0% |
| 1999 Q1 | -200 Thousand CAD | 33.33% |
| 1999 FY | -400 Thousand CAD | 63.64% |
| 1999 Q2 | -100 Thousand CAD | 50.0% |
| 1998 Q1 | -100 Thousand CAD | 0.0% |
| 1998 Q4 | -300 Thousand CAD | -200.0% |
| 1998 FY | -1.1 Million CAD | -83.33% |
| 1998 Q3 | -100 Thousand CAD | 75.0% |
| 1998 Q2 | -400 Thousand CAD | -300.0% |
| 1997 Q4 | - CAD | 100.0% |
| 1997 Q3 | -300 Thousand CAD | 0.0% |
| 1997 FY | -600 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | 364.907% |
| CanadaBis Capital Inc. | 4.67 Million CAD | -59.746% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | -429.118% |
| Delivra Health Brands Inc. | -710 Thousand CAD | 1152.273% |
| Entourage Health Corp. | -21.37 Million CAD | 134.948% |
| Lifeist Wellness Inc. | -12.24 Million CAD | 160.989% |
| Cannara Biotech Inc. | 11.88 Million CAD | 37.153% |
| Medicure Inc. | -854 Thousand CAD | 974.841% |
| PharmaCielo Ltd. | -9.7 Million CAD | 177.015% |
| Rubicon Organics Inc. | -1.08 Million CAD | 789.573% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 711.911% |